Racial/ethnic disparities in hepatocellular carcinoma treatment and survival in California, 1988-2012

World Journal of Gastroenterology

Volumn 22, Issue 38, 2016, Pages 8584-8595

  Stewart, Susan L ^a   Kwong, Sandy L ^a   Bowlus, Christopher L ^a   Nguyen, Tung T ^a   Maxwell, Annette E ^a   Bastani, Roshan ^a   Chak, Eric W ^a   Chen, Moon S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Disparities; Hepatocellular carcinoma; Liver cancer; Survival; Treatment

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ALASKA NATIVE; AMERICAN INDIAN; ARTICLE; CAMBODIAN; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER REGISTRY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CANCER THERAPY; CHINESE; CONTROLLED STUDY; ETHNIC DIFFERENCE; FEMALE; FILIPINO (PEOPLE); GEOGRAPHIC DISTRIBUTION; HEALTH DISPARITY; HISPANIC; HMONG (PEOPLE); HUMAN; JAPANESE (PEOPLE); KOREAN (PEOPLE); LAOTIAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PACIFIC ISLANDER; POPULATION RESEARCH; POPULATION RISK; RACE DIFFERENCE; RACISM; SOCIAL STATUS; SOUTH ASIAN; THAI (PEOPLE); VERY ELDERLY; VIETNAMESE; AFRICAN AMERICAN; ASIAN AMERICAN; CALIFORNIA; ETHNOLOGY; GEOGRAPHY; HEALTH CARE DISPARITY; KAPLAN MEIER METHOD; LIVER TUMOR; MIDDLE AGED; MORTALITY; ODDS RATIO; REGISTER; RISK FACTOR; SOCIAL CLASS; TREATMENT OUTCOME; UNITED STATES;

ADULT; AFRICAN AMERICANS; AGED; ASIAN AMERICANS; CALIFORNIA; CARCINOMA, HEPATOCELLULAR; FEMALE; GEOGRAPHY; HEALTH STATUS DISPARITIES; HEALTHCARE DISPARITIES; HISPANIC AMERICANS; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; MALE; MIDDLE AGED; ODDS RATIO; REGISTRIES; RISK FACTORS; SEER PROGRAM; SOCIAL CLASS; TREATMENT OUTCOME; UNITED STATES;

EID: 84991082182     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v22.i38.8584     Document Type: Article

References (59)

1. Zhu RX, Seto WK, Lai CL, Yuen MF. Epidemiology of Hepatocellular Carcinoma in the Asia-Pacific Region. Gut Liver 2016; 10: 332-339 [PMID: 27114433 DOI: 10.5009/gnl15257]
2. Ryerson AB, Eheman CR, Altekruse SF, Ward JW, Jemal A, Sherman RL, Henley SJ, Holtzman D, Lake A, Noone AM, Anderson RN, Ma J, Ly KN, Cronin KA, Penberthy L, Kohler BA. Annual Report to the Nation on the Status of Cancer, 1975-2012, featuring the increasing incidence of liver cancer. Cancer 2016; 122: 1312-1337 [PMID: 26959385 DOI: 10.1002/cncr.29936]
3. Njei B, Rotman Y, Ditah I, Lim JK. Emerging trends in hepatocellular carcinoma incidence and mortality. Hepatology 2015; 61: 191-199 [PMID: 25142309 DOI: 10.1002/hep.27388]
4. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015; 136: E359-E386 [PMID: 25220842 DOI: 10.1002/ijc.29210]
5. El-Serag HB. Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology 2012; 142: 1264-1273.e1 [PMID: 22537432 DOI: 10.1053/j.gastro.2011.12.061]
6. Kuper H, Adami HO, Trichopoulos D. Infections as a major preventable cause of human cancer. J Intern Med 2000; 248: 171-183 [PMID: 10971784]
7. Chen MS Jr, Dang J. Hepatitis B among Asian Americans: Prevalence, progress, and prospects for control. World J Gastroenterol 2015; 21: 11924-11930 [PMID: 26576081 DOI: 10.3748/wjg.v21.i42.11924]
8. El-Serag HB. Hepatocellular carcinoma. N Engl J Med 2011; 365: 1118-1127 [PMID: 21992124 DOI: 10.1056/NEJMra1001683]
9. El-Serag HB, Hampel H, Javadi F. The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence. Clin Gastroenterol Hepatol 2006; 4: 369-380 [PMID: 16527702 DOI: 10.1016/j.cgh.2005.12.007]
10. El-Serag HB, Tran T, Everhart JE. Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology 2004; 126: 460-468 [PMID: 14762783]
11. Waller LP, Deshpande V, Pyrsopoulos N. Hepatocellular carcinoma: A comprehensive review. World J Hepatol 2015; 7: 2648-2663 [PMID: 26609342 DOI: 10.4254/wjh.v7.i26.2648]
12. Altekruse SF, Henley SJ, Cucinelli JE, McGlynn KA. Changing hepatocellular carcinoma incidence and liver cancer mortality rates in the United States. Am J Gastroenterol 2014; 109: 542-553 [PMID: 24513805 DOI: 10.1038/ajg.2014.11]
13. Smith BD, Smith GL, Hurria A, Hortobagyi GN, Buchholz TA. Future of cancer incidence in the United States: burdens upon an aging, changing nation. J Clin Oncol 2009; 27: 2758-2765 [PMID: 19403886 DOI: 10.1200/JCO.2008.20.8983]
14. Petrick JL, Kelly SP, Altekruse SF, McGlynn KA, Rosenberg PS. Future of Hepatocellular Carcinoma Incidence in the United States Forecast Through 2030. J Clin Oncol 2016; 34: 1787-1794 [PMID: 27044939 DOI: 10.1200/JCO.2015.64.7412]
15. Chen MS Jr. Preventing Hepatitis B-induced Liver Cancer: Implications for Eliminating Health Disparities. J Health Dispar Res Pract 2010; 4: 88-99 [PMID: 21785754]
16. Howlader N, Noone AM, Krapcho M, Miller D, Bishop K, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2013. National Cancer Institute: Surveillance, Epidemiology, and End Results Program 2016. Available from: URL: http://seer.cancer.gov/csr/1975-2013
17. Rodriguez DN, Torruellas C, Cress RD. Trends in early-stage hepatocellular carcinoma, California 1988-2010. Cancer Causes Control 2016; 27: 325-331 [PMID: 26662039 DOI: 10.1007/ s10552-015-0705-2]
18. Harlan LC, Parsons HM, Wiggins CL, Stevens JL, Patt YZ. Treatment of hepatocellular carcinoma in the community: disparities in standard therapy. Liver Cancer 2015; 4: 70-83 [PMID: 26020030 DOI: 10.1159/000367729]
19. Njei B, Ditah I, Lim JK. Persistent racial disparities in survival among u.s. Adults with hepatocellular carcinoma after liver transplantation: the paradox of all-cause and cause-specific mortality. Gastrointest Cancer Res 2013; 6: 73-74 [PMID: 23936546]
20. Wong RJ, Corley DA. Survival differences by race/ethnicity and treatment for localized hepatocellular carcinoma within the United States. Dig Dis Sci 2009; 54: 2031-2039 [PMID: 19117131 DOI: 10.1007/s10620-008-0661-8]
21. Ha J, Yan M, Aguilar M, Bhuket T, Tana MM, Liu B, Gish RG, Wong RJ. Race/ethnicity-specific disparities in cancer incidence, burden of disease, and overall survival among patients with hepatocellular carcinoma in the United States. Cancer 2016; 122: 2512-2523 [PMID: 27195481 DOI: 10.1002/cncr.30103]
22. Sloane D, Chen H, Howell C. Racial disparity in primary hepatocellular carcinoma: tumor stage at presentation, surgical treatment and survival. J Natl Med Assoc 2006; 98: 1934-1939 [PMID: 17225837]
23. Kwong SL, Stewart SL, Aoki CA, Chen MS Jr. Disparities in hepatocellular carcinoma survival among Californians of Asian ancestry, 1988 to 2007. Cancer Epidemiol Biomarkers Prev 2010; 19: 2747-2757 [PMID: 20823106 DOI: 10.1158/1055-9965. EPI-10-0477]
24. Kwong SL, Chen MS Jr, Snipes KP, Bal DG, Wright WE. Asian subgroups and cancer incidence and mortality rates in California. Cancer 2005; 104: 2975-2981 [PMID: 16247792 DOI: 10.1002/ cncr.21511]
25. NAACCR Race and Ethnicity Work Group. NAACCR Asian Pacific Islander identification algorithm (NAPIIA v1.2.1). Springfield, IL: North American Association of Central Cancer Registries, 2011
26. NAACCR Race and Ethnicity Work Group. NAACCR guideline for enhancing Hispanic/Latino identification: revised NAACR Hispanic/Latino identification algorithm (NHIA v2.2.1). Springfield, IL: North American Association of Central Cancer Registries, 2011
27. Fang DM, Lee S, Stewart S, Ly MY, Chen MS Jr. Factors associated with pap testing among Hmong women. J Health Care Poor Underserved 2010; 21: 839-850 [PMID: 20693730 DOI: 10.1353/ hpu.0.0338]
28. Yang RC, Mills PK, Riordan DG. Cervical cancer among Hmong women in California, 1988 to 2000. Am J Prev Med 2004; 27: 132-138 [PMID: 15261900 DOI: 10.1016/j.amepre.2004.04.003]
29. Shankar LD, Srikanth R. A Part, Yet Apart. South Asians in Asian America: Temple University Press, 1998
30. Parikh-Patel A, Mills PK, Jain RV. Breast cancer survival among South Asian women in California (United States). Cancer Causes Control 2006; 17: 267-272 [PMID: 16489534 DOI: 10.1007/ s10552-005-0520-2]
31. Yost K, Perkins C, Cohen R, Morris C, Wright W. Socioeconomic status and breast cancer incidence in California for different race/ ethnic groups. Cancer Causes Control 2001; 12: 703-711 [PMID: 11562110]
32. Yang J, Schupp CW, Harrati A Clark C, Keegan THM, Gomez SL. Developing an area-based socioeconomic measure from American Community Survey data. Fremont, California: Cancer Prevention Institute of California, 2014
33. Robbins AS, Daily MF, Aoki CA, Chen MS Jr, Troppmann C, Perez RV. Decreasing disparity in liver transplantation among white and Asian patients with hepatocellular carcinoma: California, 1998-2005. Cancer 2008; 113: 2173-2179 [PMID: 18792066 DOI: 10.1002/cncr.23766]
34. Ha J, Yan M, Aguilar M, Tana M, Liu B, Frenette CT, Bhuket T, Wong RJ. Race/Ethnicity-specific Disparities in Hepatocellular Carcinoma Stage at Diagnosis and its Impact on Receipt of Curative Therapies. J Clin Gastroenterol 2016; 50: 423-430 [PMID: 26583267 DOI: 10.1097/MCG.0000000000000448]
35. Robbins AS, Cox DD, Johnson LB, Ward EM. Persistent disparities in liver transplantation for patients with hepatocellular carcinoma in the United States, 1998 through 2007. Cancer 2011; 117: 4531-4539 [PMID: 21448933 DOI: 10.1002/cncr.26063]
36. Mathur AK, Osborne NH, Lynch RJ, Ghaferi AA, Dimick JB, Sonnenday CJ. Racial/ethnic disparities in access to care and survival for patients with early-stage hepatocellular carcinoma. Arch Surg 2010; 145: 1158-1163 [PMID: 21173289 DOI: 10.1001/ archsurg.2010.272]
37. Dohmen K, Shigematsu H, Irie K, Ishibashi H. Longer survival in female than male with hepatocellular carcinoma. J Gastroenterol Hepatol 2003; 18: 267-272 [PMID: 12603526]
38. Flores YN, Yee HF, Leng M, Escarce JJ, Bastani R, Salmerón J, Morales LS. Risk factors for chronic liver disease in Blacks, Mexican Americans, and Whites in the United States: results from NHANES IV, 1999-2004. Am J Gastroenterol 2008; 103: 2231-2238 [PMID: 18671818 DOI: 10.1111/j.1572-0241.2008.02022.x]
39. Trevisani F, Frigerio M, Santi V, Grignaschi A, Bernardi M. Hepatocellular carcinoma in non-cirrhotic liver: a reappraisal. Dig Liver Dis 2010; 42: 341-347 [PMID: 19828388 DOI: 10.1016/ j.dld.2009.09.002]
40. Schütte K, Schulz C, Poranzke J, Antweiler K, Bornschein J, Bretschneider T, Arend J, Ricke J, Malfertheiner P. Characterization and prognosis of patients with hepatocellular carcinoma (HCC) in the non-cirrhotic liver. BMC Gastroenterol 2014; 14: 117 [PMID: 24990270 DOI: 10.1186/1471-230X-14-117]
41. Shindoh J, Hashimoto M, Watanabe G. Surgical approach for hepatitis C virus-related hepatocellular carcinoma. World J Hepatol 2015; 7: 70-77 [PMID: 25624998 DOI: 10.4254/wjh.v7.i1.70]
42. Bozorgzadeh A, Orloff M, Abt P, Tsoulfas G, Younan D, Kashyap R, Jain A, Mantry P, Maliakkal B, Khorana A, Schwartz S. Survival outcomes in liver transplantation for hepatocellular carcinoma, comparing impact of hepatitis C versus other etiology of cirrhosis. Liver Transpl 2007; 13: 807-813 [PMID: 17539001 DOI: 10.1002/ lt.21054]
43. Dillon ST, Bhasin MK, Feng X, Koh DW, Daoud SS. Quantitative proteomic analysis in HCV-induced HCC reveals sets of proteins with potential significance for racial disparity. J Transl Med 2013; 11: 239 [PMID: 24283668 DOI: 10.1186/1479-5876-11-239]
44. Maxwell AE, Stewart SL, Glenn BA, Wong WK, Yasui Y, Chang LC, Taylor VM, Nguyen TT, Chen MS Jr, Bastani R. Theoretically informed correlates of hepatitis B knowledge among four Asian groups: the health behavior framework. Asian Pac J Cancer Prev 2012; 13: 1687-1692 [PMID: 22799389 DOI: 10.1007/ s11606-010-1285-1]
45. Burnham B, Wallington S, Jillson IA, Trandafili H, Shetty K, Wang J, Loffredo CA. Knowledge, attitudes, and beliefs of patients with chronic liver disease. Am J Health Behav 2014; 38: 737-744 [PMID: 24933143 DOI: 10.5993/AJHB.38.5.11]
46. Safo SA, Batchelder A, Peyser D, Litwin AH. The common sense model applied to hepatitis C: a qualitative analysis of the impact of disease comparison and witnessed death on hepatitis C illness perception. Harm Reduct J 2015; 12: 20 [PMID: 26092261 DOI: 10.1186/s12954-015-0054-1]
47. Chen H, Tu SP, Teh CZ, Yip MP, Choe JH, Hislop TG, Taylor VM, Thompson B. Lay beliefs about hepatitis among North American Chinese: implications for hepatitis prevention. J Community Health 2006; 31: 94-112 [PMID: 16737171]
48. Wu CA, Lin SY, So SK, Chang ET. Hepatitis B and liver cancer knowledge and preventive practices among Asian Americans in the San Francisco Bay Area, California. Asian Pac J Cancer Prev 2007; 8: 127-134 [PMID: 17477787]
49. Chao SD, Wang BM, Chang ET, Ma L, So SK. Medical training fails to prepare providers to care for patients with chronic hepatitis B infection. World J Gastroenterol 2015; 21: 6914-6923 [PMID: 26078568 DOI: 10.3748/wjg.v21.i22.6914]
50. Robotin M, Patton Y, George J. Getting it right: the impact of a continuing medical education program on hepatitis B knowledge of Australian primary care providers. Int J Gen Med 2013; 6: 115-122 [PMID: 23662074 DOI: 10.2147/IJGM.S41299]
51. Upadhyaya N, Chang R, Davis C, Conti MC, Salinas-Garcia D, Tang H. Chronic hepatitis B: perceptions in Asian American communities and diagnosis and management practices among primary care physicians. Postgrad Med 2010; 122: 165-175 [PMID: 20861600 DOI: 10.3810/pgm.2010.09.2213]
52. Smith BD, Morgan RL, Beckett GA, Falck-Ytter Y, Holtzman D, Teo CG, Jewett A, Baack B, Rein DB, Patel N, Alter M, Yartel A, Ward JW. Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965. MMWR Recomm Rep 2012; 61: 1-32 [PMID: 22895429]
53. Zeremski M, Zibbell JE, Martinez AD, Kritz S, Smith BD, Talal AH. Hepatitis C virus control among persons who inject drugs requires overcoming barriers to care. World J Gastroenterol 2013; 19: 7846-7851 [PMID: 24307778 DOI: 10.3748/wjg.v19.i44.7846]
54. Ha NB, Trinh HN, Nguyen TT, Leduc TS, Bui C, Ha NB, Wong CR, Tran AT, Nguyen MH. Prevalence, risk factors, and disease knowledge of chronic hepatitis B infection in Vietnamese Americans in California. J Cancer Educ 2013; 28: 319-324 [PMID: 23564428 DOI: 10.1007/s13187-013-0466-0]
55. Ditah I, Al Bawardy B, Gonzalez HC, Saberi B, Ditah C, Kamath PS, Charlton M. Lack of health insurance limits the benefits of hepatitis C virus screening: insights from the National Health and Nutrition Examination Hepatitis C follow-up study. Am J Gastroenterol 2015; 110: 1126-1133 [PMID: 25756239 DOI: 10.1038/ajg.2015.31]
56. Dang JH, Chen MS Jr. Increasing Hepatitis B Testing and Linkage to Care of Foreign-Born Asians, Sacramento, California, 2012-2013. Public Health Rep 2016; 131 Suppl 2: 119-124 [PMID: 27168671]
57. Chang ET, Yang J, Alfaro-Velcamp T, So SK, Glaser SL, Gomez SL. Disparities in liver cancer incidence by nativity, acculturation, and socioeconomic status in California Hispanics and Asians. Cancer Epidemiol Biomarkers Prev 2010; 19: 3106-3118 [PMID: 20940276 DOI: 10.1158/1055-9965.EPI-10-0863]
58. Jim MA, Perdue DG, Richardson LC, Espey DK, Redd JT, Martin HJ, Kwong SL, Kelly JJ, Henderson JA, Ahmed F. Primary liver cancer incidence among American Indians and Alaska Natives, US, 1999-2004. Cancer 2008; 113: 1244-1255 [PMID: 18720380 DOI: 10.1002/cncr.23728]
59. Gomez SL, Clarke CA, Shema SJ, Chang ET, Keegan TH, Glaser SL. Disparities in breast cancer survival among Asian women by ethnicity and immigrant status: a population-based study. Am J Public Health 2010; 100: 861-869 [PMID: 20299648 DOI: 10.2105/AJPH.2009.176651]